Application of Ncgl0030 gene and mutant thereof in promoting synthesis of L-lysine

By modifying the Ncgl0030 gene and its mutants, recombinant microorganisms were prepared, which solved the problem of insufficient L-lysine production capacity in existing technologies, and achieved a significant increase in L-lysine yield and optimization of fermentation process.

CN118931986APending Publication Date: 2024-11-12NINGXIA EPPEN BIOTECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410470470.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-04-18
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

Existing technologies are insufficient to effectively increase the production capacity of L-lysine, thus failing to meet the growing demand.

Method used

By introducing and modifying the Ncgl0030 gene and its mutants, recombinant microorganisms were prepared. These genes were used to regulate the synthesis of L-lysine, including gene substitution, overexpression, and deletion, to optimize fermentation conditions and increase L-lysine production.

Benefits of technology

It significantly increased the production of L-lysine, met market demand, and optimized the fermentation process, thereby improving production efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004798749550000101
    Figure BDA0004798749550000101
  • Figure BDA0004798749550000111
    Figure BDA0004798749550000111
  • Figure BDA0004798749550000112
    Figure BDA0004798749550000112
Patent Text Reader

Abstract

The invention discloses an application of an Ncgl0030 gene and a mutant of the Ncgl0030 gene in promoting synthesis of L-lysine. The invention provides an application of an Ncgl0030 gene or a biological material related to the Ncgl0030 gene or a mutant gene or a biological material related to the mutant gene in preparation of a product for improving the capacity of microorganisms for producing L-lysine. The invention also provides an application of the Ncgl0030 protein or the mutant protein in production of L-lysine by positively regulating microorganisms. And the Ncgl0030 gene is a gene for coding an Ncgl0030 protein. The mutant gene is a gene for coding mutant protein. The Ncgl0030 protein comprises an amino acid sequence as shown in SEQ ID NO: 2. The mutant protein is the mutant protein of the Ncgl0030 protein. The inventor finds that improvement of the expression activity (point mutation or overexpression) of the Ncgl0030 gene in microorganisms is beneficial to accumulation of L-lysine.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology and relates to the application of Ncgl0030 gene and its mutant in promoting L-lysine synthesis. Background Art

[0002] Lysine, chemical name is 2,6-diaminohexanoic acid. Lysine is an alkaline essential amino acid that cannot be synthesized by the body and must be supplemented from food. Lysine is mainly found in animal foods and beans. The lysine content in cereal foods is very low and is easily destroyed and lacking during processing, so it is called the first limiting amino acid. Lysine is easily soluble in water. Compared with other amino acids, lysine is the easiest to absorb orally. In 2007, the WHO / FAO / UNU Expert Committee determined the lysine requirement to be 30 mg kg based on the results of relevant human trials. -1 ·d -1 This value is currently widely recognized. The lysine requirement for infants, young children and adolescents determined by WHO / FAO is (mg·kg -1 ·d -1 ): 1 month old (119), 2 months old (87), 3 months old (75), 4 months old (68), 6 months old (65), 1-2 years old (45), 3-10 years old (35), 11-14 years old (35), 15-18 years old (33). Lysine has positive nutritional significance in promoting human growth and development, enhancing immunity, anti-virus, promoting fat oxidation, and relieving anxiety. It can also promote the absorption of certain nutrients and can work synergistically with some nutrients to better play the physiological functions of various nutrients. Lysine can regulate the metabolic balance of the human body. Lysine provides structural components for the synthesis of carnitine, and carnitine promotes the synthesis of fatty acids in cells. Adding a small amount of lysine to food can stimulate the secretion of pepsin and gastric acid, improve the secretion of gastric juice, and play a role in increasing appetite and promoting the growth and development of young children. Lysine can also improve the absorption of calcium and its accumulation in the body, accelerating bone growth. Lack of lysine can cause insufficient secretion of gastric juice, leading to anorexia and nutritional anemia, resulting in central nervous system obstruction and stunted development. Lysine can also be used as an adjuvant drug for diuretics in medicine to treat lead poisoning caused by reduced chloride in the blood. It can also form salts with acidic drugs (such as salicylic acid) to reduce adverse reactions. When used in combination with methionine, it can inhibit severe hypertension. Studies have also shown that supplementing lysine can accelerate the recovery of herpes infection and inhibit its recurrence.

[0003] Only the L-form of lysine is absorbed by organisms, and the CAS number of L-lysine is 56-87-1. L-lysine is widely used in various fields, and its global demand increases every year. Therefore, various studies are being conducted to develop efficient microbial strains and fermentation process technologies for producing L-lysine. For example, key genes involved in the synthesis of L-lysine are overexpressed in microbial strains to increase their activity; or genes that do not need to be expressed (byproducts or toxins that affect cell growth, etc.) are deleted in microbial strains. However, as the demand for L-lysine increases year by year, research is still needed to effectively increase the production capacity of L-lysine. Summary of the invention

[0004] The purpose of the present invention is to provide the application of Ncgl0030 gene and its mutant in promoting L-lysine synthesis.

[0005] The present invention provides the use of Ncgl0030 gene or Ncgl0030 gene related biological materials or mutant genes or mutant gene related biological materials in preparing products for improving the ability of microorganisms to produce L-lysine.

[0006] The present invention also provides the use of the Ncgl0030 gene or mutant gene in positively regulating the production of L-lysine by microorganisms.

[0007] The present invention also provides the use of Ncgl0030 protein or mutant protein in positively regulating microbial production of L-lysine.

[0008] The present invention also provides a recombinant microorganism, which is as follows (a1) or (a2) or (a3):

[0009] (a1) introducing the Ncgl0030 gene or Ncgl0030 gene-related biological material into a host microorganism to obtain a recombinant microorganism;

[0010] (a2) introducing a mutant gene or a mutant gene-related biological material into a host microorganism to obtain a recombinant microorganism;

[0011] (a3) Replacing the Ncgl0030 gene in the host microorganism genome with a mutant gene to obtain a recombinant microorganism.

[0012] The present invention also provides application of the recombinant microorganism in preparing L-lysine.

[0013] The Ncgl0030 gene is a gene encoding the Ncgl0030 protein.

[0014] The mutant gene is a gene encoding a mutant protein.

[0015] Specifically, the Ncgl0030 protein comprises the amino acid sequence shown in SEQ ID NO:2.

[0016] Exemplarily, the Ncgl0030 protein is shown in SEQ ID NO:2.

[0017] Exemplarily, the Ncgl0030 protein consists of the protein shown in SEQ ID NO: 2 and a tag protein.

[0018] The mutant protein is obtained by mutating one or several amino acid residues of the Ncgl0030 protein.

[0019] Specifically, the mutant protein is obtained by mutating the 184th amino acid residue in the amino acid sequence shown in SEQ ID NO: 2 in the Ncgl0030 protein from asparagine to other amino acids.

[0020] Specifically, the mutant protein is obtained by mutating the 184th amino acid residue in the amino acid sequence shown in SEQ ID NO: 2 in the Ncgl0030 protein from asparagine to isoleucine.

[0021] Specifically, the mutant protein comprises the amino acid sequence shown in SEQ ID NO:4.

[0022] Exemplarily, the mutant protein is shown in SEQ ID NO:4.

[0023] Exemplarily, the mutant protein consists of the protein shown in SEQ ID NO:4 and a tag protein.

[0024] Specifically, the Ncgl0030 gene comprises the nucleotide sequence shown in SEQ ID NO:1.

[0025] Exemplarily, the Ncgl0030 gene is shown as SEQ ID NO:1.

[0026] Exemplarily, the Ncgl0030 gene consists of the segment shown in SEQ ID NO: 1 and a segment encoding a tag protein.

[0027] Specifically, the mutant gene is obtained by subjecting the Ncgl0030 gene to one or several nucleotide mutations.

[0028] Specifically, the mutant gene is obtained by mutating one or several codons of the Ncgl0030 gene.

[0029] Specifically, the mutant gene is obtained by mutating the codon encoding the 184th amino acid residue in the amino acid sequence shown in SEQ ID NO: 2 in the Ncgl0030 gene from a codon encoding asparagine to a codon encoding other amino acids.

[0030] Specifically, the mutant gene is obtained by mutating the codon encoding the 184th amino acid residue of the amino acid sequence shown in SEQ ID NO: 2 in the Ncgl0030 gene from a codon encoding asparagine to a codon encoding isoleucine.

[0031] Specifically, the mutant gene comprises the nucleotide sequence shown in SEQ ID NO:3.

[0032] Exemplarily, the mutant gene is shown in SEQ ID NO:3.

[0033] Exemplarily, the mutant gene consists of the segment shown in SEQ ID NO: 3 and a segment encoding a tag protein.

[0034] The Ncgl0030 gene-related biological material is an expression cassette or a recombinant vector having the Ncgl0030 gene.

[0035] Exemplarily, the recombinant vector having the Ncgl0030 gene is a recombinant expression vector obtained by inserting the Ncgl0030 gene into an expression vector.

[0036] Exemplarily, the expression vector is pK18mobsacB plasmid or pXMJ19 plasmid.

[0037] Exemplarily, the recombinant expression vector may be the recombinant plasmid pK18-Ncgl0030OE or the recombinant plasmid pXMJ19-Ncgl0030.

[0038] Recombinant plasmid pK18-Ncgl0030OE: A recombinant plasmid obtained by replacing "AGGATCCCC" in the pK18mobsacB plasmid with a specific DNA molecule (composed, from upstream to downstream, of a double-stranded DNA molecule represented by SEQ ID NO:7, a double-stranded DNA molecule represented by positions 415-1898 in SEQ ID NO:5, and a double-stranded DNA molecule represented by SEQ ID NO:8).

[0039] Recombinant plasmid pXMJ19-Ncgl0030: A recombinant plasmid obtained by replacing "tctagaggatccccg" in the pXMJ19 plasmid with the double-stranded DNA molecule represented by positions 415-1898 in SEQ ID NO:5.

[0040] The mutant gene-related biological material is an expression box or a recombinant vector having the mutant gene.

[0041] Exemplarily, the recombinant vector having the mutant gene is a recombinant expression vector obtained by inserting the mutant gene into an expression vector.

[0042] Exemplarily, the expression vector is pK18mobsacB plasmid or pXMJ19 plasmid.

[0043] Exemplarily, the recombinant expression vector may be a recombinant plasmid pK18-Ncgl0030 N184I , recombinant plasmid pK18-Ncgl0030 N184I OE or recombinant plasmid pXMJ19-Ncgl0030 N184I .

[0044] Recombinant plasmid pK18-Ncgl0030 N184I : The recombinant plasmid obtained by replacing "AGGATCCCC" in the pK18mobsacB plasmid with the double-stranded DNA molecule shown in SEQ ID NO:6.

[0045] Recombinant plasmid pK18-Ncgl0030 N184I OE: A recombinant plasmid obtained by replacing "AGGATCCCC" in the pK18mobsacB plasmid with a specific DNA molecule (composed of the double-stranded DNA molecule shown in SEQ ID NO: 7, the double-stranded DNA molecule shown in SEQ ID NO: 9, and the double-stranded DNA molecule shown in SEQ ID NO: 8 from upstream to downstream).

[0046] Recombinant plasmid pXMJ19-Ncgl0030 N184I : The recombinant plasmid obtained by replacing "tctagaggatccccg" in the pXMJ19 plasmid with the double-stranded DNA molecule shown in SEQ ID NO:9.

[0047] Exemplarily, the recombinant microorganism may be recombinant bacteria Y-Ncgl0030-1, recombinant bacteria Y-Ncgl0030-2, recombinant bacteria Y-Ncgl0030-3, recombinant bacteria Y-Ncgl0030-4, recombinant bacteria Y-Ncgl0030-5, recombinant bacteria L-Ncgl0030-1, recombinant bacteria L-Ncgl0030-2, recombinant bacteria L-Ncgl0030-3, recombinant bacteria L-Ncgl0030-4 or recombinant bacteria L-Ncgl0030-5.

[0048] Compared with the genomic DNA of Corynebacterium glutamicum YP097158, the genomic DNA of the recombinant bacterium L-Ncgl0030-1 differs only in that: Ncgl0030 shown in SEQ ID NO: 3 N184I The gene coding region replaces the wild-type Ncgl0030 gene coding region shown in SEQ ID NO:1.

[0049] Compared with the genomic DNA of Corynebacterium glutamicum YP097158, the genomic DNA of the recombinant strain L-Ncgl0030-3 differs only in that the segment between the upstream homology arm shown in SEQ ID NO:7 and the downstream homology arm shown in SEQ ID NO:8 in the genomic DNA is replaced by the double-stranded DNA molecule shown in SEQ ID NO:9. The genomic DNA of the recombinant strain L-Ncgl0030-3 contains one copy of the wild-type Ncgl0030 gene and one copy of the Ncgl0030 gene. N184I Gene.

[0050] Compared with the genomic DNA of the recombinant strain L-Ncgl0030-3, the genomic DNA of the recombinant strain L-Ncgl0030-2 differs only in that the wild-type Ncgl0030 gene coding region shown in SEQ ID NO:1 replaces the Ncgl0030 gene shown in SEQ ID NO:3 in the exogenous fragment integrated into the genomic DNA. N184I Gene coding region: The genomic DNA of the recombinant bacterium L-Ncgl0030-2 contains two copies of the wild-type Ncgl0030 gene.

[0051] Recombinant bacteria L-Ncgl0030-4: The recombinant plasmid pXMJ19-Ncgl0030 was introduced into Corynebacterium glutamicum YP097158 to obtain the recombinant bacteria L-Ncgl0030-4.

[0052] Recombinant bacteria L-Ncgl0030-5: recombinant plasmid pXMJ19-Ncgl0030 N184I Introduce Corynebacterium glutamicum YP097158 to obtain the recombinant bacterium L-Ncgl0030-5.

[0053] Compared with the genomic DNA of Corynebacterium glutamicum ATCC13032, the genomic DNA of the recombinant bacterium Y-Ncgl0030-1 differs only in that: Ncgl0030 shown in SEQ ID NO:3 N184I The gene coding region replaces the wild-type Ncgl0030 gene coding region shown in SEQ ID NO:1.

[0054] Compared with the genomic DNA of Corynebacterium glutamicum ATCC13032, the genomic DNA of the recombinant bacterium Y-Ncgl0030-3 differs only in that the segment between the upstream homology arm shown in SEQ ID NO:7 and the downstream homology arm shown in SEQ ID NO:8 in the genomic DNA is replaced by the double-stranded DNA molecule shown in SEQ ID NO:9. The genomic DNA of the recombinant bacterium Y-Ncgl0030-3 contains one copy of the wild-type Ncgl0030 gene and one copy of the Ncgl0030 gene. N184I Gene.

[0055] Compared with the genomic DNA of the recombinant strain Y-Ncgl0030-3, the genomic DNA of the recombinant strain Y-Ncgl0030-2 differed only in that the wild-type Ncgl0030 gene coding region shown in SEQ ID NO:1 replaced the Ncgl0030 gene shown in SEQ ID NO:3 in the exogenous fragment integrated into the genomic DNA. N184I Gene coding region: The genomic DNA of the recombinant bacterium Y-Ncgl0030-2 contains two copies of the wild-type Ncgl0030 gene.

[0056] Recombinant bacteria Y-Ncgl0030-4: The recombinant plasmid pXMJ19-Ncgl0030 was introduced into Corynebacterium glutamicum ATCC13032 to obtain the recombinant bacteria Y-Ncgl0030-4.

[0057] Recombinant bacteria Y-Ncgl0030-5: recombinant plasmid pXMJ19-Ncgl0030 N184I Introduce Corynebacterium glutamicum ATCC13032 to obtain the recombinant bacterium Y-Ncgl0030-5.

[0058] The method for preparing L-lysine using the recombinant microorganism comprises the following steps: fermenting the recombinant microorganism.

[0059] Those skilled in the art can use the fermentation method in the prior art for fermentation. The fermentation method can also be optimized and improved by conventional experiments. The fermentation of bacteria can be carried out in a suitable culture medium under fermentation conditions known in the art. The culture medium may contain: a carbon source, a nitrogen source, trace elements, and a combination thereof. During the culture, the pH of the culture can be adjusted. In addition, the culture can include preventing the generation of bubbles, such as by using a defoamer to prevent the generation of bubbles. In addition, the culture can include injecting gas into the culture. The gas can include any gas that can maintain the aerobic conditions of the culture. During the culture, the temperature of the culture can be 20 to 45°C.

[0060] The method may further comprise the step of obtaining lysine from the culture. Obtaining lysine from the culture may be achieved in various ways, including but not limited to treating the culture with sulfuric acid or hydrochloric acid, followed by a combination of methods such as anion exchange chromatography, concentration, crystallization, and isoelectric precipitation.

[0061] In the fermentation, the formula of the exemplary fermentation medium is shown in Table 3, and the balance is water.

[0062] In the fermentation, exemplary fermentation control processes are shown in Table 4.

[0063] Exemplarily, during the fermentation, at the initial moment of inoculation, the system OD 600nm The value can be 0.3-0.5.

[0064] Specifically, any of the above-mentioned microorganisms can be bacteria.

[0065] Any of the above bacteria include, but are not limited to, the following: Corynebacterium bacteria, preferably Corynebacterium acetoacidophilum, Corynebacterium acetoglutamicum, Corynebacterium callunae, Corynebacterium glutamicum, Brevibacterium flavum, Brevibacterium lactofermentum, Corynebacterium ammoniagenes, Corynebacterium pekinense, Brevibacterium saccharolyticum, Brevibacterium roseum, and Brevibacterium thiogenitalis.

[0066] Any of the above-mentioned bacteria is a bacterium capable of producing lysine.

[0067] "Bacteria having the ability to produce lysine" means that the bacteria have the ability to produce and accumulate lysine in a culture medium and / or in bacterial cells. Thus, lysine can be collected when the bacteria are cultured in a culture medium.

[0068] The bacteria may be wild-type bacteria collected naturally or modified bacteria.

[0069] "Modified bacteria" refers to modified bacteria obtained by artificially mutating and / or inducing mutations in naturally collected wild-type bacteria.

[0070] Specifically, the Corynebacterium glutamicum may be Corynebacterium glutamicum ATCC13032 or Corynebacterium glutamicum YP097158.

[0071] The lysine mentioned above refers to lysine in a broad sense, including free lysine, lysine salts or a mixture of the two.

[0072] Specifically, the lysine is L-lysine.

[0073] Any of the above methods or applications can also be used for the preparation of downstream products of lysine.

[0074] The L-lysine may be replaced by other products.

[0075] The recombinant microorganism may be replaced by a recombinant biological cell.

[0076] That is, the recombinant biological cell can be used to produce a variety of products, including but not limited to the lysine in the embodiment. The products produced can also be glutamic acid, valine, glycine, alanine, leucine, isoleucine, methionine, proline, tryptophan, serine, tyrosine, cysteine, phenylalanine, asparagine, glutamine, threonine, aspartic acid, arginine, histidine, shikimic acid, protocatechuic acid, succinic acid, alpha-ketoglutaric acid, citric acid, ornithine and citrulline, etc.

[0077] The Ncg10030 gene belongs to the ABC transport protein (MEMBRANECOMPONENT) of the cell membrane and is one of the components of the cell membrane. Its specific mechanism and function have never been reported before. After years of continuous research and practice, and with some luck, the inventors found that increasing the expression activity of the Ncg10030 gene (point mutation or overexpression) in microorganisms is conducive to the accumulation of L-lysine. DETAILED DESCRIPTION

[0078] The present invention is further described in detail below in conjunction with specific embodiments, and the examples provided are only for illustrating the present invention, rather than for limiting the scope of the present invention. The examples provided below can be used as a guide for further improvements by those of ordinary skill in the art, and do not constitute a limitation of the present invention in any way.

[0079] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are carried out according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels. Unless otherwise specified, the quantitative tests in the following examples are set up with three repeated experiments, and the results are averaged. pK18mobsacB plasmid, double-stranded circular DNA (as shown in SEQ ID NO: 13). pXMJ19 plasmid: BioVector plasmid vector strain cell gene storage center. NEBuilder enzyme: NEB company.

[0080] Corynebacterium glutamicum ATCC13032, i.e., Corynebacterium glutamicum numbered 13032 in ATCC.

[0081] Corynebacterium glutamicum YP097158 was deposited in the General Microbiology Center of China Culture Collection Administration (CGMCC for short, address: No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences) on August 16, 2016, with the deposit registration number of CGMCC No.12856.

[0082] Sequencing confirmed that the genomic DNA of Corynebacterium glutamicum ATCC13032 and Corynebacterium glutamicum YP097158 both had the following segments: the segment shown in SEQ ID NO:5 (wherein positions 415-726 are the promoter and positions 727-1752 are the wild-type Ncgl0030 gene), the segment shown in SEQ ID NO:7 (corresponding to the partial coding region of the NCgl1740 gene and

[0083] NCgl1741 gene promoter region and partial coding region), the segment shown in SEQ ID NO:8 (corresponding to the partial coding region of NCgl1742 gene).

[0084] The coding region of the wild-type Ncgl0030 gene is shown in SEQ ID NO: 1, encoding the wild-type Ncgl0030 protein shown in SEQ ID NO: 2. N184I The coding region of the gene is shown in SEQ ID NO:3, encoding Ncgl0030 shown in SEQ ID NO:4 N184I Compared with the wild-type Ncgl0030 protein, Ncgl0030 N184IThe difference of the protein is that the amino acid residue 184 is mutated from asparagine (N) to isoleucine (I). N184I The only difference between the genes is that the 551st nucleotide in the coding region has mutated from A to T.

[0085] Solid culture medium A (pH 7.0): contains 10 g / L sucrose, 10 g / L polypeptone, 10 g / L beef extract, 5 g / L yeast powder, 2 g / L urea, 2.5 g / L sodium chloride and 18 g / L agar powder, the balance is water. Solid culture medium B (pH 7.0): contains 150 g / L sucrose, 10 g / L polypeptone, 10 g / L beef extract, 5 g / L yeast powder, 2 g / L urea, 2.5 g / L sodium chloride and 18 g / L agar powder, the balance is water. Non-antibacterial plate: solid culture medium A plate. Antibacterial plate: solid culture medium A plate containing 50 mg / L kanamycin.

[0086] Example 1: Construction of Ncgl0030 N184I Recombinant bacteria with homologous gene replacement of wild-type Ncgl0030 gene

[0087] 1. Construction of expression of Ncgl0030 N184I Recombinant gene vector

[0088] 1. Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, PCR amplification was performed using a primer pair consisting of P1 and P2, and the amplified product was recovered.

[0089] 2. Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, PCR amplification was performed using a primer pair consisting of P3 and P4, and the amplified product was recovered.

[0090] 3. Double digest the pK18mobsacB plasmid with restriction endonucleases Xbal I and BamH I to recover a linearized plasmid backbone of approximately 6 kb.

[0091] 4. The amplified product obtained in step 1, the amplified product obtained in step 2, and the linearized plasmid backbone obtained in step 3 were connected using NEBuilder enzyme (50°C, 30 min) to obtain the recombinant plasmid pK18-Ncgl0030. N184I Recombinant plasmid pK18-Ncgl0030 N184I The recombinant plasmid pK18-Ncgl0030 has been sequenced and verified. N184I The only difference is that the double-stranded DNA molecule shown in SEQ ID NO:6 replaces the "AGGATCCCC" in the pK18mobsacB plasmid.

[0092] 2. Preparation of recombinant bacteria L-Ncgl0030-1

[0093] 1. Recombinant plasmid pK18-Ncgl0030 N184I The glutamicum YP097158 was introduced by electroporation, and then cultured on a solid medium A plate containing 50 mg / L kanamycin at 30°C for 40 hours. A single colony was picked, and PCR amplification was performed using a primer pair consisting of P1 and P4, and the amplified product was recovered for sequencing verification. The strain with the sequencing result shown in SEQ ID No. 6 was the target strain.

[0094] 2. Streak the target strain obtained in step 1 onto a solid culture medium B plate and culture at 30°C for 40 h.

[0095] 3. After completing step 2, pick a single colony from the plate and inoculate it on a non-antibacterial plate and an antibacterial plate respectively. Select the strain that does not grow on the antibacterial plate but grows on the non-antibacterial plate, which is the target strain.

[0096] 4. Take the target strain obtained in step 3, use the primer pair consisting of P1 and P4 to perform PCR amplification and recover the amplified product for sequencing verification. If the amplified product contains Ncgl0030 N184I The strain has the gene coding region and does not have the wild-type Ncgl0030 gene coding region, and the strain is the recombinant strain L-Ncgl0030-1.

[0097] The sequencing results showed that the genomic DNA of the recombinant bacterium L-Ncgl0030-1 was different from that of the genomic DNA of Corynebacterium glutamicum YP097158 only in that: N184I The gene coding region replaces the wild-type Ncgl0030 gene coding region shown in SEQ ID NO:1.

[0098] 3. Preparation of recombinant bacteria Y-Ncgl0030-1

[0099] Corynebacterium glutamicum ATCC13032 was used to replace Corynebacterium glutamicum YP097158, and the rest was the same as step 2.

[0100] The recombinant bacteria Y-Ncgl0030-1 was obtained.

[0101] The sequencing results showed that the genomic DNA of the recombinant bacterium Y-Ncgl0030-1 was different from that of the genomic DNA of Corynebacterium glutamicum ATCC13032 in that: N184IThe gene coding region replaces the wild-type Ncgl0030 gene coding region shown in SEQ ID NO:1.

[0102] Example 2: Construction of a genome-wide overexpression of the wild-type Ncgl0030 gene or Ncgl0030 N184I Gene recombinant bacteria

[0103] 1. Construction of recombinant plasmid pK18-Ncgl0030OE

[0104] 1. Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, a primer pair consisting of P5 and P6 was used for PCR amplification, and the amplified product was recovered. The amplified product was sequenced and verified to have an upstream homology arm shown in SEQ ID NO:7.

[0105] 2. Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, a primer pair consisting of P7 and P8 was used for PCR amplification, and the amplified product was recovered. The amplified product was verified by sequencing as shown in positions 415-1898 of SEQ ID NO:5.

[0106] 3. Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, a primer pair consisting of P9 and P10 was used for PCR amplification, and the amplified product was recovered. The amplified product was sequenced and verified to have the downstream homology arm shown in SEQ ID NO:8.

[0107] 4. Double digest the pK18mobsacB plasmid with restriction endonucleases Xbal I and BamH I to recover a linearized plasmid backbone of approximately 6 kb.

[0108] 5. The amplification product obtained in step 1, the amplification product obtained in step 2, the amplification product obtained in step 3 and the linearized plasmid backbone obtained in step 4 were connected using NEBuilder enzyme (50°C, 30min) to obtain the recombinant plasmid pK18-Ncgl0030OE. The recombinant plasmid pK18-Ncgl0030OE has been sequenced and verified. Compared with the pK18mobsacB plasmid, the difference between the recombinant plasmid pK18-Ncgl0030OE is that the "AGGATCCCC" in the pK18mobsacB plasmid is replaced by a specific DNA molecule (composed of the double-stranded DNA molecule shown in SEQ ID NO:7, the double-stranded DNA molecule shown in positions 415-1898 in SEQ ID NO:5, and the double-stranded DNA molecule shown in SEQ ID NO:8, from upstream to downstream).

[0109] 2. Construction of recombinant plasmid pK18-Ncgl0030 N184I OE

[0110] 1. Using the genomic DNA of the recombinant bacterium L-Ncgl0030-1 as a template, PCR amplification was performed using the primer pair consisting of P5 and P6, and the amplified product was recovered.

[0111] 2. Using the genomic DNA of the recombinant bacterium L-Ncgl0030-1 as a template, PCR amplification was performed using the primer pair consisting of P7 and P8, and the amplified product was recovered.

[0112] 3. Using the genomic DNA of the recombinant bacterium L-Ncgl0030-1 as a template, PCR amplification was performed using the primer pair consisting of P9 and P10, and the amplified product was recovered.

[0113] 4. Double digest the pK18mobsacB plasmid with restriction endonucleases Xbal I and BamH I to recover a linearized plasmid backbone of approximately 6 kb.

[0114] 5. The amplified product obtained in step 1, the amplified product obtained in step 2, the amplified product obtained in step 3 and the linearized plasmid backbone obtained in step 4 were connected using NEBuilder enzyme (50°C, 30min) to obtain the recombinant plasmid pK18-Ncgl0030. N184I OE. Recombinant plasmid pK18-Ncgl0030 N184I OE has been sequenced and verified. Compared with pK18mobsacB plasmid, recombinant plasmid pK18-Ncgl0030 N184I The only difference of OE is that the "AGGATCCCC" in the pK18mobsacB plasmid is replaced by a specific DNA molecule (composed of the double-stranded DNA molecule shown in SEQ ID NO: 7, the double-stranded DNA molecule shown in SEQ ID NO: 9, and the double-stranded DNA molecule shown in SEQ ID NO: 8 from upstream to downstream).

[0115] 3. Preparation of recombinant bacteria L-Ncgl0030-3

[0116] 1. Recombinant plasmid pK18-Ncgl0030 N184I OE was electroporated into Corynebacterium glutamicum YP097158, and then solid medium A was used to culture for 40 hours at 30°C. A single colony was picked, and a primer pair consisting of P11 and P12 was used for PCR amplification and the amplified product was recovered for sequencing verification. If the amplified product was 1631 bp, the bacterium was the target bacterium. The sequencing result of the amplified product is shown in SEQ ID NO: 10.

[0117] 2. The target bacteria obtained in step 1 were streaked onto a solid culture medium B plate and cultured at 30°C for 40 hours. A single colony was picked and PCR amplified using a primer pair consisting of P13 and P14, and the amplified product was recovered for sequencing verification. If the amplified product was 1282 bp, the bacterium was the target bacterium, i.e., the recombinant bacterium L-Ncgl0030-3. The sequencing result of the amplified product is shown in SEQ ID NO: 11.

[0118] Sequencing confirmed that the only difference between the genomic DNA of the recombinant bacterium L-Ncgl0030-3 and the genomic DNA of Corynebacterium glutamicum YP097158 was that the double-stranded DNA molecule shown in SEQ ID NO: 9 replaced the segment between the upstream homology arm shown in SEQ ID NO: 7 and the downstream homology arm shown in SEQ ID NO: 8 in the genomic DNA. The genomic DNA of the recombinant bacterium L-Ncgl0030-3 contained one copy of the wild-type Ncgl0030 gene and one copy of the Ncgl0030 gene. N184I Gene.

[0119] 4. Preparation of recombinant bacteria L-Ncgl0030-2

[0120] 1. The recombinant plasmid pK18-Ncgl0030OE was introduced into Corynebacterium glutamicum YP097158 by electroporation, and then cultured on solid medium A plate at 30°C for 40 hours. Pick a single colony, use the primer pair composed of P11 and P12 for PCR amplification, and recover the amplified product for sequencing verification. If the amplified product is 1631bp, the bacterium is the target bacterium.

[0121] 2. The target bacteria obtained in step 1 were streaked onto a solid culture medium B plate and cultured at 30°C for 40 hours. A single colony was picked and PCR amplified using the primer pair consisting of P13 and P14, and the amplified product was recovered for sequencing verification. If the amplified product was 1282 bp, the bacterium was the target bacterium, i.e., the recombinant bacterium L-Ncgl0030-2.

[0122] Sequencing confirmed that the only difference between the genomic DNA of the recombinant strain L-Ncgl0030-2 and that of the recombinant strain L-Ncgl0030-3 was that the wild-type Ncgl0030 gene coding region shown in SEQ ID NO:1 replaced the Ncgl0030 gene coding region shown in SEQ ID NO:3 in the exogenous fragment integrated into the genomic DNA. N184I Gene coding region: The genomic DNA of the recombinant bacterium L-Ncgl0030-2 contains two copies of the wild-type Ncgl0030 gene.

[0123] 5. Preparation of recombinant bacteria Y-Ncgl0030-3

[0124] Corynebacterium glutamicum ATCC13032 was used to replace Corynebacterium glutamicum YP097158, and the rest was the same as step 3.

[0125] The recombinant bacteria Y-Ncgl0030-3 were obtained.

[0126] Sequencing confirmed that the only difference between the genomic DNA of the recombinant bacterium Y-Ncgl0030-3 and the genomic DNA of Corynebacterium glutamicum ATCC13032 was that the double-stranded DNA molecule shown in SEQ ID NO:9 replaced the segment between the upstream homology arm shown in SEQ ID NO:7 and the downstream homology arm shown in SEQ ID NO:8 in the genomic DNA. The genomic DNA of the recombinant bacterium Y-Ncgl0030-3 contained one copy of the wild-type Ncgl0030 gene and one copy of the Ncgl0030 gene. N184I Gene.

[0127] VI. Preparation of recombinant bacteria Y-Ncgl0030-2

[0128] Corynebacterium glutamicum ATCC13032 was used to replace Corynebacterium glutamicum YP097158, and the rest was the same as step 4.

[0129] The recombinant bacteria Y-Ncgl0030-2 was obtained.

[0130] Sequencing confirmed that the only difference between the genomic DNA of the recombinant strain Y-Ncgl0030-2 and that of the recombinant strain Y-Ncgl0030-3 was that the wild-type Ncgl0030 gene coding region shown in SEQ ID NO:1 replaced the Ncgl0030 gene shown in SEQ ID NO:3 in the exogenous fragment integrated into the genomic DNA. N184I Gene coding region: The genomic DNA of the recombinant bacterium Y-Ncgl0030-2 contains two copies of the wild-type Ncgl0030 gene.

[0131] Example 3: Construction of plasmids to overexpress wild-type Ncgl0030 gene or Ncgl0030 N184I Gene recombinant bacteria

[0132] 1. Construction of recombinant plasmid pXMJ19-Ncgl0030 N184I

[0133] 1. Using the genomic DNA of the recombinant bacterium L-Ncgl0030-1 as a template, PCR amplification was performed using the primer pair consisting of P15 and P16, and the amplified product was recovered.

[0134] 2. Double digest the pXMJ19 plasmid with restriction endonucleases Xbal I and BamH I to recover a linearized plasmid backbone of approximately 6 kb.

[0135] 3. The amplified product obtained in step 1 and the linearized plasmid backbone obtained in step 2 were connected using NEBuilder enzyme (50°C, 30 min) to obtain the recombinant plasmid pXMJ19-Ncgl0030 N184I Recombinant plasmid pXMJ19-Ncgl0030 N184I The recombinant plasmid pXMJ19-Ncgl0030 has been sequenced and verified. N184I The only difference is that the double-stranded DNA molecule shown in SEQ ID NO:9 replaces the "tctagaggatccccg" in the pXMJ19 plasmid.

[0136] 2. Construction of recombinant plasmid pXMJ19-Ncgl0030

[0137] 1. Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, a primer pair consisting of P15 and P16 was used for PCR amplification, and the amplified product was recovered.

[0138] 2. Double digest the pXMJ19 plasmid with restriction endonucleases Xbal I and BamH I to recover a linearized plasmid backbone of approximately 6 kb.

[0139] 3. The amplified product obtained in step 1 and the linearized plasmid backbone obtained in step 2 were connected using NEBuilder enzyme (50°C, 30 min) to obtain the recombinant plasmid pXMJ19-Ncgl0030. The recombinant plasmid pXMJ19-Ncgl0030 has been sequenced and verified. Compared with the pXMJ19 plasmid, the difference between the recombinant plasmid pXMJ19-Ncgl0030 is that the double-stranded DNA molecule shown at positions 415-1898 in SEQ ID NO: 5 replaces the "tctagaggatccccg" in the pXMJ19 plasmid.

[0140] 3. Preparation of recombinant bacteria

[0141] The recombinant plasmid pXMJ19-Ncgl0030 was introduced into Corynebacterium glutamicum YP097158 to obtain the recombinant bacterium L-Ncgl0030-4.

[0142] The recombinant plasmid pXMJ19-Ncgl0030 N184I Introduce Corynebacterium glutamicum YP097158 to obtain the recombinant bacterium L-Ncgl0030-5.

[0143] The recombinant plasmid pXMJ19-Ncgl0030 was introduced into Corynebacterium glutamicum ATCC13032 to obtain the recombinant bacterium Y-Ncgl0030-4.

[0144] The recombinant plasmid pXMJ19-Ncgl0030 N184I Introduce Corynebacterium glutamicum ATCC13032 to obtain the recombinant bacterium Y-Ncgl0030-5.

[0145] Example 4: Construction of a recombinant bacterium lacking the wild-type Ncgl0030 gene in the genome

[0146] 1. Preparation of recombinant plasmid pK18-ΔNcgl0030

[0147] 1. Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, a primer pair consisting of P17 and P18 was used for PCR amplification, and the amplified product was recovered.

[0148] 2. Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, PCR amplification was performed using a primer pair consisting of P19 and P20, and the amplified product was recovered.

[0149] 3. Double digest the pK18mobsacB plasmid with restriction endonucleases Xbal I and BamH I to recover a linearized plasmid backbone of approximately 6 kb.

[0150] 4. The amplified product obtained in step 1, the amplified product obtained in step 2, and the linearized plasmid backbone obtained in step 3 were connected using NEBuilder enzyme (50°C, 30 min) to obtain the recombinant plasmid pK18-ΔNcgl0030. The recombinant plasmid pK18-ΔNcgl0030 has been sequenced and verified. Compared with the pK18mobsacB plasmid, the difference between the recombinant plasmid pK18-ΔNcgl0030 is that the double-stranded DNA molecule shown in SEQ ID NO: 12 replaces the "AGGATCCCC" in the pK18mobsacB plasmid.

[0151] 2. Preparation of recombinant bacteria L-Ncgl0030-6

[0152] 1. The recombinant plasmid pK18-ΔNcgl0030 was introduced into Corynebacterium glutamicum YP097158 by electroporation, and then cultured on solid medium A plate at 30°C for 40 hours. Single colonies were picked and PCR amplified using primer pairs consisting of P17 and P20. Strains that could simultaneously amplify bands of 1522 bp and 2091 bp were positive strains.

[0153] 2. Streak the positive strain obtained in step 1 onto a solid culture medium B plate and culture at 30°C for 40 h.

[0154] 3. After completing step 2, pick a single colony from the plate and inoculate it on a non-antimicrobial plate and an antimicrobial plate respectively. Select the strain that does not grow on the antimicrobial plate but grows on the non-antimicrobial plate as the positive strain.

[0155] 4. Take the positive strain obtained in step 3 and use the primer pair composed of P17 and P20 for PCR amplification. The strain that can only amplify a 1522bp band is the positive strain, that is, the recombinant strain L-Ncgl0030-6.

[0156] Sequencing confirmed that the only difference between the genomic DNA of the recombinant bacterium L-Ncgl0030-6 and the genomic DNA of Corynebacterium glutamicum YP097158 was that the DNA molecule shown in SEQ ID NO: 12 replaced the DNA molecule shown in SEQ ID NO: 5.

[0157] 3. Preparation of recombinant bacteria Y-Ncgl0030-6

[0158] Corynebacterium glutamicum ATCC13032 was used to replace Corynebacterium glutamicum YP097158, and the rest was the same as step 2.

[0159] The recombinant bacteria Y-Ncgl0030-6 were obtained.

[0160] Sequencing confirmed that the only difference between the genomic DNA of the recombinant bacterium Y-Ncgl0030-6 and that of the Corynebacterium glutamicum ATCC13032 was that the DNA molecule shown in SEQ ID NO:5 was replaced by the DNA molecule shown in SEQ ID NO:12.

[0161] Example 5, L-Lysine fermentation experiment

[0162] Test strains: Corynebacterium glutamicum ATCC13032, recombinant bacteria Y-Ncgl0030-1, recombinant bacteria Y-Ncgl0030-2, recombinant bacteria Y-Ncgl0030-3, recombinant bacteria Y-Ncgl0030-4, recombinant bacteria Y-Ncgl0030-5, recombinant bacteria Y-Ncgl0030-6; Corynebacterium glutamicum YP097158, recombinant bacteria L-Ncgl0030-1, recombinant bacteria L-Ncgl0030-2, recombinant bacteria L-Ncgl0030-3, recombinant bacteria L-Ncgl0030-4, recombinant bacteria L-Ncgl0030-5, recombinant bacteria L-Ncgl0030-6.

[0163] The fermentation was carried out in a BLBIO-5GC-4-H fermenter (Shanghai Bailun Biotechnology Co., Ltd.). The formula of the fermentation medium is shown in Table 1. The fermentation control process is shown in Table 2. At the initial moment of inoculation, the system OD 600nm The value was 0.3-0.5. After the fermentation, the L-lysine production was detected by ninhydrin colorimetry. At least 3 biological replicates were set, and the results were taken as the mean ± standard deviation.

[0164] The method for detecting the lysine production of the fermentation broth by ninhydrin staining is as follows:

[0165] ① After fermentation, centrifuge at 5000rpm / min for 5min and collect the supernatant.

[0166] ② Take a 96-well plate and add 5 μL of the supernatant obtained in step ①, 0.066 mL of solution I and 0.037 mL of solution II to each well, mix well, and cover tightly with a gelatin 96-well sealing lid.

[0167] Solution I: 630 mL buffer + 6 g ferric chloride + 373 mL methyl cellosolve. Solution II: 1 g ninhydrin dissolved in 100 mL buffer. Buffer (pH 2.2): weigh 1.43 g Na 2 HPO 4 and 18.8g of anhydrous citric acid, add water to 1L.

[0168] ③After completing step ②, the 96-well plate was kept at a constant temperature of 100°C for 40 minutes, and then quickly cooled to room temperature with water.

[0169] ④After completing step ③, add 200 μL DMSO to each well and mix thoroughly.

[0170] ⑤After completing step ④, sample 200 μL into a 96-well ELISA plate and measure the absorption peak at 480 nm using an ELISA reader.

[0171] A standard curve was prepared using L-lysine standards, and the L-lysine yield was calculated using the absorption peak.

[0172] The results are shown in Tables 3 and 4. Overexpression of wild-type Ncgl0030 gene or Ncgl0030 in Corynebacterium glutamicum N184I The wild-type Ncgl0030 gene in Corynebacterium glutamicum was site-directed mutated into Ncgl0030 N184I The gene helps to increase the production of L-lysine. Knocking out the wild-type Ncgl0030 gene in Corynebacterium glutamicum reduces the production of L-lysine. Compared with overexpressing the wild-type Ncgl0030 gene, overexpressing Ncgl0030 in Corynebacterium glutamicum N184IThe gene can significantly increase L-lysine production.

[0173] Table 1 Fermentation medium formula

[0174] Element Concentration in culture medium Starch hydrolyzed sugar 30g / L Ammonium sulfate 12g / L Magnesium sulfate 0.87g / L Molasses 20g / L Acidified corn syrup 3mL / L Phosphoric acid 0.4mL / L Potassium chloride 0.53g / L Defoaming agent (2% foaming agent) 4mL / L Ferrous Sulfate 120mg / L Manganese sulfate 120mg / L Niacinamide 42mg / L Calcium Pantothenate 6.3mg / L Vitamin B1 6.3mg / L Copper sulfate 0.9mg / L Zinc sulfate 1.0mg / L Biotin 0.88mg / L

[0175] Note: Corn syrup comes from Ningxia Yipin Biotechnology Co., Ltd.

[0176] Table 2 Fermentation control process

[0177]

[0178]

[0179] Table 3 Fermentation yield of modified bacteria using Corynebacterium glutamicum ATCC13032 as starting bacteria

[0180]

[0181] Table 4 Fermentation yield of modified bacteria using Corynebacterium glutamicum YP097158 as starting bacteria

[0182]

[0183] P1: 5'- CAGTGCCAAGCTTGCATGCCTGCAGGTCGACTCTAG TGACCGCTATTCGTGATG-3′;

[0184] P2: 5'-CAAAAAACAGTGATGCGAATAATCACACCAAAGATG-3';

[0185] P3: 5'-CATCTTTGGTGTGATTATTCGCATCACTGTTTTTTG-3';

[0186] P4: 5'- CAGCTATGACCATGATTACGAATTCGAGCTCGGTACCC GAGAATCTTGATGAGGGTGG-3'.

[0187] P5: 5'- CAGTGCCAAGCTTGCATGCCTGCAGGTCGACTCTAG AATGCGTTCTGGACTGAGG-3′;

[0188] P6: 5'-GAGTCCCACAACCCAATCAGTGCACCGAGAACAGATG-3';

[0189] P7: 5'-CATCTGTTCTCGGTGCACTGATTGGGTTGTGGGACTC-3';

[0190] P8: 5'-GATTTAATTGCGCCATCTGGAGAATCTTGATGAGGGTGG-3';

[0191] P9: 5'-CCACCCTCATCAAGATTCTCCAGATGGCGCAATTAAATC-3';

[0192] P10: 5'- CAGCTATGACCATGATTACGAATTCGAGCTCGGTACCC GCTATGACACCTTCAACGGATC-3'.

[0193] P11: 5′-TCCAAGGAAGATACACGCC-3′ (corresponding to the outside of the upstream homology arm);

[0194] P12: 5′-GCAGCATAAGGAAAGTGGC-3′ (corresponding to the inside of Ncgl0030 gene);

[0195] P13: 5′-TGCTGTTTGTTATCGTCGG-3′ (corresponding to the inside of Ncgl0030 gene);

[0196] P14: 5'-TGGTCGTTGGAATCTTGC-3' (corresponding to the outside of the downstream homology arm).

[0197] P15: 5'- CAGAATAATTAAGCTTTGCATGCCTGCAGGTCGAC TGATTGGGTTGTGGGACTC-3′;

[0198] P16: 5'- CCAAAACAGCCAAGCTGAATTCGAGCTCGGTACC GAGAATCTTGATGAGGGTGG-3'.

[0199] P17: 5'- CAGTGCCAAGCTTGCATGCCTGCAGGTCGACTCTAG CCCTGAACAATCCAACCTC-3′;

[0200] P18: 5'-CCGACGATAACAAACAGCATTTGTCATCGCAGACCCTC-3';

[0201] P19: 5'-GAGGGTCTGCGATGACAAATGCTGTTTGTTATCGTCGG-3';

[0202] P20: 5'- CAGCTATGACCATGATTACGAATTCGAGCTCGGTACCC GTTTCAGAACGCCAAATCG-3'.

[0203] In the above primers, the underlined region is used for homologous recombination with the same sequence on the plasmid backbone.

[0204] The present invention has been described in detail above. It will be apparent to those skilled in the art that the present invention may be implemented in a wide range under equivalent parameters, concentrations and conditions without departing from the spirit and scope of the present invention and without the need for unnecessary experimentation. Although the present invention provides specific embodiments, it should be understood that further improvements may be made to the present invention. In short, according to the principles of the present invention, this application intends to include any changes, uses or improvements to the present invention, including changes made by conventional techniques known in the art that depart from the scope disclosed in this application. Applications of some of the basic features may be made within the scope of the following appended claims.

Claims

1. Use of Ncgl0030 gene or Ncgl0030 gene related biological materials or mutant genes or mutant gene related biological materials in the preparation of products for improving the ability of microorganisms to produce L-lysine; The Ncgl0030 gene is a gene encoding the Ncgl0030 protein; The Ncgl0030 gene-related biological material is an expression cassette or a recombinant vector having the Ncgl0030 gene; The mutant gene is a gene encoding a mutant protein; The mutant gene-related biological material is an expression cassette or a recombinant vector having the mutant gene; The mutant protein is obtained by mutating one or several amino acid residues of the Ncgl0030 protein.

2. Application of Ncgl0030 gene or mutant gene in positively regulating microbial production of L-lysine; The Ncgl0030 gene is as described in claim 1; The mutant gene is as described in claim 1.

3. Application of Ncgl0030 protein or mutant protein in positively regulating microbial production of L-lysine; The mutant protein is obtained by mutating one or several amino acid residues of the Ncgl0030 protein.

4. The use according to claim 1, 2 or 3, characterized in that: The Ncgl0030 protein comprises the amino acid sequence shown in SEQ ID NO:

2.

5. The use according to claim 4, characterized in that: The mutant protein is obtained by mutating the 184th amino acid residue of the amino acid sequence shown in SEQ ID NO: 2 in the Ncgl0030 protein from asparagine to other amino acids.

6. The use according to claim 4, characterized in that: The mutant protein is obtained by mutating the 184th amino acid residue in the amino acid sequence shown in SEQ ID NO: 2 in the Ncgl0030 protein from asparagine to isoleucine.

7. The use according to claim 4, characterized in that: The mutant gene is obtained by mutating the codon encoding the 184th amino acid residue of the amino acid sequence shown in SEQ ID NO: 2 in the Ncgl0030 gene from a codon encoding asparagine to a codon encoding other amino acids.

8. The use according to claim 4, characterized in that: The mutant gene is obtained by mutating the codon encoding the 184th amino acid residue in the amino acid sequence shown in SEQ ID NO: 2 in the Ncgl0030 gene from a codon encoding asparagine to a codon encoding isoleucine.

9. A recombinant microorganism, which is (a1) or (a2) or (a3) ​​as follows: (a1) introducing the Ncgl0030 gene or Ncgl0030 gene-related biological material into a host microorganism to obtain a recombinant microorganism; (a2) introducing a mutant gene or a mutant gene-related biological material into a host microorganism to obtain a recombinant microorganism; (a3) replacing the Ncgl0030 gene in the genome of the host microorganism with a mutant gene to obtain a recombinant microorganism; The Ncgl0030 gene is as described in claim 1; The mutant gene is as described in claim 1; The Ncgl0030 gene-related biological material is as described in claim 1; The mutant gene-related biological material is as described in claim 1.

10. Use of the recombinant microorganism according to claim 9 in the preparation of L-lysine.